source
- Aspen Neuroscience raises $140M IPO to advance Parkinson’s cell therapyAspen Neuroscience, a San Diego biotechnology company, completed an initial public offering, selling roughly 9.4 million shares at $15 each and raising about $140.6 million. The capital will be di…
- Bracco to invest $230M in new US contrast media plant, creating 200 jobsBracco Diagnostics announced a $230 million investment to build its first U.S. manufacturing facility for injectable contrast media in Sanford, North Carolina. The plant is slated to create about…